QA: Castle Biosciences INC in us_health_services/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001447362_2026_Castle_Biosciences_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001447362, Castle Biosciences INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 18,564,000
2 AssetsCurrent 361,097,000
3 PropertyPlantAndEquipment 97,443,000
4 remainder_Assets 101,452,000
5 LongTermLiabilities 34,857,000
6 LiabilitiesCurrent 71,012,000
7 remainder_Liabilities 1,814,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 71,028,000
10 GeneralAndAdministrativeExpense 229,323,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 51,850,000
16 remainder_Expenses 29,568,000
17 remainder_Revenues 344,229,000
18 remainder_NetIncome 13,382,000
19 remainder_ComprehensiveNetIncome 37,000
  yvar yval
0 Assets 578,556,000
1 Liabilities 107,683,000
2 Expenses 381,769,000
3 Revenues 344,229,000
4 StockholdersEquity 470,873,000
5 NetIncome -24,158,000
6 ComprehensiveNetIncome -24,121,000
7 BaseVar 712,828,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.92
9 EconomicCapitalRatio 2.33

Edgar->Model Mapping

Feature Distribution

Change over Time